Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for a ketorolac tromethamine product by Fresenius Kabi USA, LLC under the ANDA pathway. This action adds a generic ketor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)